导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -29.33% | 1041/1050 |
| 近一周 | -2.84% | 751/1104 |
| 近一月 | -10.40% | 1050/1102 |
| 近一季 | -27.70% | 1075/1092 |
| 近半年 | -34.89% | 1061/1070 |
| 近一年 | -8.03% | 713/1018 |
| 近两年 | 28.79% | 690/926 |
| 近三年 | 1.95% | 657/834 |
| 成立以来 | 401.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.37% 306/1070 |
3.53% 642/1101 |
- - |
- - |
| 2025 | 54.32% 153/1065 |
5.51% 374/1014 |
- 684/1038 |
23.16% 507/1050 |
18.76% 11/1065 |
| 2024 | -1.71% 629/1011 |
-3.54% 507/960 |
-4.97% 636/983 |
12.82% 398/991 |
-4.96% 666/1011 |
| 2023 | -12.61% 421/952 |
7.33% 204/880 |
-6.87% 638/895 |
-8.78% 541/915 |
-4.16% 419/952 |
| 2022 | -23.02% 438/867 |
-17.88% 420/773 |
4.86% 524/806 |
-13.86% 507/845 |
3.78% 252/867 |
| 2021 | 14.60% 194/740 |
-1.06% 194/580 |
14.98% 236/659 |
-7.34% 431/704 |
8.72% 108/740 |
| 2020 | 63.24% 173/554 |
4.24% 83/419 |
27.07% 161/466 |
11.82% 208/517 |
10.23% 352/554 |
| 2019 | 73.04% 26/410 |
46.21% 21/1149 |
-8.07% 909/1231 |
14.88% 40/390 |
12.07% 107/410 |
| 2018 | -19.10% 61/349 |
- - |
- - |
- - |
-8.94% 202/1080 |
| 2017 | 5.74% 153/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.56% 58/205 |
- - |
- - |
- - |
- - |
| 2015 | 37.32% 41/151 |
- - |
- - |
- - |
- - |
| 2014 | 17.84% 16/24 |
- - |
- - |
- - |
- - |
| 2013 | 9.08% 15/21 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 诺安研究精选股票 VS. 东吴新产业精选股票A(580008) |